netupitant Articles

Vifor gets certain rights to Helsinn's netupitant-palonosetron

16 May 2013

Helsinn out-licenses netupitant-palonosetron fixed dose combo in South Korea

25 September 2012

Helsinn moving forward with supportive cancer care products anamorelin and netupitant + palonosetron

26 September 2011

Helsinn and Taiho Pharma to extend relationship with CINV drug accord

14 April 2011

Helsinn Healthcare and Eisai extend relationship, including US Aloxi marketing

10 June 2010

Showing 1-5 of 5 articles

Go to beginningPrevious
  • 1
NextGo to end